Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Insomnia Medication market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Insomnia Medicationmarket, defines the market attractiveness level of Insomnia Medication market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Insomnia Medication industry, describes the types of Insomnia Medication market, the applications of major players and the market size, and deeply analyzes the current situation of the global Insomnia Medication market and the development prospects and opportunities of Insomnia Medication industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Insomnia Medication market in Chapter 13.
By Player:
Sanofi
Johnson & Johnson
Neurim
Pernix Therapeutics
Takeda
Merck
Eisai
Vanda Pharmaceuticals
Paratek Pharmaceuticals
Minerva Neurosciences
Purdue Pharma
Flynn Pharma
SkyePharma
Somnus Therapeutics
ECR Pharmaceuticals (Valeant)
Astellas
Pfizer
Meda
Dainippon Sumitomo
By Type:
Nonbenzodiazepine Receptor Agonists
Benzodiazepine Receptor Agonists
The Selective Melatonin Receptor Agonist Ramelteon
Sedating Antidepressants
By End-User:
Adults
Kids
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Insomnia Medication Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Insomnia Medication Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Insomnia Medication Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Insomnia Medication Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Insomnia Medication Market Analysis and Outlook to 2022
-
7.1 Global Insomnia Medication Consumption (2017-2022)
-
7.2 United States Insomnia Medication Consumption (2017-2022)
-
7.3 Europe Insomnia Medication Consumption (2017-2022)
-
7.4 China Insomnia Medication Consumption (2017-2022)
-
7.5 Japan Insomnia Medication Consumption (2017-2022)
-
7.6 India Insomnia Medication Consumption (2017-2022)
-
7.7 South Korea Insomnia Medication Consumption (2017-2022)
8 Region and Country-wise Insomnia Medication Market Analysis and Outlook to 2028
-
8.1 Global Insomnia Medication Consumption Forecast (2022-2028)
-
8.2 United States Insomnia Medication Consumption Forecast (2022-2028)
-
8.3 Europe Insomnia Medication Consumption Forecast (2022-2028)
-
8.4 China Insomnia Medication Consumption Forecast (2022-2028)
-
8.5 Japan Insomnia Medication Consumption Forecast (2022-2028)
-
8.6 India Insomnia Medication Consumption Forecast (2022-2028)
-
8.7 South Korea Insomnia Medication Consumption Forecast (2022-2028)
9 Global Insomnia Medication Market Outlook by Types and Applications to 2022
-
9.1 Global Insomnia Medication Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Nonbenzodiazepine Receptor Agonists Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Benzodiazepine Receptor Agonists Consumption and Growth Rate (2017-2022)
-
9.1.3 Global The Selective Melatonin Receptor Agonist Ramelteon Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Sedating Antidepressants Consumption and Growth Rate (2017-2022)
-
9.2 Global Insomnia Medication Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Adults Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Kids Consumption and Growth Rate (2017-2022)
10 Global Insomnia Medication Market Outlook by Types and Applications to 2028
-
10.1 Global Insomnia Medication Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Nonbenzodiazepine Receptor Agonists Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Benzodiazepine Receptor Agonists Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global The Selective Melatonin Receptor Agonist Ramelteon Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Sedating Antidepressants Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Insomnia Medication Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Kids Consumption Forecast and Growth Rate (2022-2028)
11 Global Insomnia Medication Import and Export Analysis (Top 5 Countries)
-
11.1 Global Insomnia Medication Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Insomnia Medication Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Insomnia Medication Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Insomnia Medication Market Competitive Analysis
-
14.1 Sanofi
-
14.1.1 Sanofi Company Details
-
14.1.2 Sanofi Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sanofi Insomnia Medication Product and Service
-
14.2 Johnson & Johnson
-
14.2.1 Johnson & Johnson Company Details
-
14.2.2 Johnson & Johnson Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Johnson & Johnson Insomnia Medication Product and Service
-
14.3 Neurim
-
14.3.1 Neurim Company Details
-
14.3.2 Neurim Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Neurim Insomnia Medication Product and Service
-
14.4 Pernix Therapeutics
-
14.4.1 Pernix Therapeutics Company Details
-
14.4.2 Pernix Therapeutics Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pernix Therapeutics Insomnia Medication Product and Service
-
14.5 Takeda
-
14.5.1 Takeda Company Details
-
14.5.2 Takeda Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Takeda Insomnia Medication Product and Service
-
14.6 Merck
-
14.6.1 Merck Company Details
-
14.6.2 Merck Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Merck Insomnia Medication Product and Service
-
14.7 Eisai
-
14.7.1 Eisai Company Details
-
14.7.2 Eisai Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Eisai Insomnia Medication Product and Service
-
14.8 Vanda Pharmaceuticals
-
14.8.1 Vanda Pharmaceuticals Company Details
-
14.8.2 Vanda Pharmaceuticals Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Vanda Pharmaceuticals Insomnia Medication Product and Service
-
14.9 Paratek Pharmaceuticals
-
14.9.1 Paratek Pharmaceuticals Company Details
-
14.9.2 Paratek Pharmaceuticals Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Paratek Pharmaceuticals Insomnia Medication Product and Service
-
14.10 Minerva Neurosciences
-
14.10.1 Minerva Neurosciences Company Details
-
14.10.2 Minerva Neurosciences Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Minerva Neurosciences Insomnia Medication Product and Service
-
14.11 Purdue Pharma
-
14.11.1 Purdue Pharma Company Details
-
14.11.2 Purdue Pharma Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Purdue Pharma Insomnia Medication Product and Service
-
14.12 Flynn Pharma
-
14.12.1 Flynn Pharma Company Details
-
14.12.2 Flynn Pharma Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Flynn Pharma Insomnia Medication Product and Service
-
14.13 SkyePharma
-
14.13.1 SkyePharma Company Details
-
14.13.2 SkyePharma Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 SkyePharma Insomnia Medication Product and Service
-
14.14 Somnus Therapeutics
-
14.14.1 Somnus Therapeutics Company Details
-
14.14.2 Somnus Therapeutics Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Somnus Therapeutics Insomnia Medication Product and Service
-
14.15 ECR Pharmaceuticals (Valeant)
-
14.15.1 ECR Pharmaceuticals (Valeant) Company Details
-
14.15.2 ECR Pharmaceuticals (Valeant) Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Product and Service
-
14.16 Astellas
-
14.16.1 Astellas Company Details
-
14.16.2 Astellas Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Astellas Insomnia Medication Product and Service
-
14.17 Pfizer
-
14.17.1 Pfizer Company Details
-
14.17.2 Pfizer Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 Pfizer Insomnia Medication Product and Service
-
14.18 Meda
-
14.18.1 Meda Company Details
-
14.18.2 Meda Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
14.18.3 Meda Insomnia Medication Product and Service
-
14.19 Dainippon Sumitomo
-
14.19.1 Dainippon Sumitomo Company Details
-
14.19.2 Dainippon Sumitomo Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
14.19.3 Dainippon Sumitomo Insomnia Medication Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Insomnia Medication
-
Figure Insomnia Medication Picture
-
Table Global Insomnia Medication Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Insomnia Medication Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Insomnia Medication Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Insomnia Medication Consumption by Country (2017-2022)
-
Figure United States Insomnia Medication Consumption and Growth Rate (2017-2022)
-
Table Europe Insomnia Medication Consumption and Growth Rate (2017-2022)
-
Figure China Insomnia Medication Consumption and Growth Rate (2017-2022)
-
Figure Japan Insomnia Medication Consumption and Growth Rate (2017-2022)
-
Figure India Insomnia Medication Consumption and Growth Rate (2017-2022)
-
Figure South Korea Insomnia Medication Consumption and Growth Rate (2017-2022)
-
Figure Global Insomnia Medication Consumption Forecast by Country (2022-2028)
-
Figure United States Insomnia Medication Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Insomnia Medication Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Insomnia Medication Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Insomnia Medication Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Insomnia Medication Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Insomnia Medication Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nonbenzodiazepine Receptor Agonists Consumption and Growth Rate (2017-2022)
-
Figure Global Benzodiazepine Receptor Agonists Consumption and Growth Rate (2017-2022)
-
Figure Global The Selective Melatonin Receptor Agonist Ramelteon Consumption and Growth Rate (2017-2022)
-
Figure Global Sedating Antidepressants Consumption and Growth Rate (2017-2022)
-
Figure Global Adults Consumption and Growth Rate (2017-2022)
-
Figure Global Kids Consumption and Growth Rate (2017-2022)
-
Figure Global Nonbenzodiazepine Receptor Agonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Benzodiazepine Receptor Agonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global The Selective Melatonin Receptor Agonist Ramelteon Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sedating Antidepressants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kids Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Insomnia Medication Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Insomnia Medication Export by Region (Top 5 Countries) (2017-2028)
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Insomnia Medication Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Insomnia Medication Product and Service
-
Table Neurim (Foundation Year, Company Profile and etc.)
-
Table Neurim Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
Table Neurim Insomnia Medication Product and Service
-
Table Pernix Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Pernix Therapeutics Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pernix Therapeutics Insomnia Medication Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Insomnia Medication Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Insomnia Medication Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Insomnia Medication Product and Service
-
Table Vanda Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Vanda Pharmaceuticals Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vanda Pharmaceuticals Insomnia Medication Product and Service
-
Table Paratek Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Paratek Pharmaceuticals Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
Table Paratek Pharmaceuticals Insomnia Medication Product and Service
-
Table Minerva Neurosciences (Foundation Year, Company Profile and etc.)
-
Table Minerva Neurosciences Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
Table Minerva Neurosciences Insomnia Medication Product and Service
-
Table Purdue Pharma (Foundation Year, Company Profile and etc.)
-
Table Purdue Pharma Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
Table Purdue Pharma Insomnia Medication Product and Service
-
Table Flynn Pharma (Foundation Year, Company Profile and etc.)
-
Table Flynn Pharma Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
Table Flynn Pharma Insomnia Medication Product and Service
-
Table SkyePharma (Foundation Year, Company Profile and etc.)
-
Table SkyePharma Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
Table SkyePharma Insomnia Medication Product and Service
-
Table Somnus Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Somnus Therapeutics Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
Table Somnus Therapeutics Insomnia Medication Product and Service
-
Table ECR Pharmaceuticals (Valeant) (Foundation Year, Company Profile and etc.)
-
Table ECR Pharmaceuticals (Valeant) Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
Table ECR Pharmaceuticals (Valeant) Insomnia Medication Product and Service
-
Table Astellas (Foundation Year, Company Profile and etc.)
-
Table Astellas Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Insomnia Medication Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Insomnia Medication Product and Service
-
Table Meda (Foundation Year, Company Profile and etc.)
-
Table Meda Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
Table Meda Insomnia Medication Product and Service
-
Table Dainippon Sumitomo (Foundation Year, Company Profile and etc.)
-
Table Dainippon Sumitomo Insomnia Medication Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dainippon Sumitomo Insomnia Medication Product and Service
-
